Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Assets
Cash and due from banks	$ 25,334	$ 25,321
Interest bearing deposits with banks	478,495	571,232
Cash and cash equivalents	503,829	596,553
Investment securities available for sale, at fair value	11,810	13,351
Investment securities held to maturity (fair value of $9,058 at March 31, 2022 and $10,025 at December 31, 2021)	9,897	9,918
Total investment securities	21,707	23,269
Loans, net of unearned income	1,495,839	1,484,847
Less: Allowance for loan losses	(29,981)	(29,845)
Net loans	1,465,858	1,455,002
Accrued interest receivable	7,344	7,681
Premises and equipment, net	6,185	6,265
Restricted stock	5,157	5,144
Bank owned life insurance (BOLI)	27,715	27,577
Deferred tax asset	7,742	7,608
Other	8,654	7,346
Total assets	2,054,191	2,136,445
Deposits
Noninterest-bearing deposits	471,940	553,810
Interest-bearing deposits	1,205,270	1,214,600
Total deposits	1,677,210	1,768,410
FHLBNY borrowings	78,150	78,150
Subordinated debentures	42,779	42,732
Accrued interest payable	1,029	1,603
Other	14,744	13,189
Total liabilities	1,813,912	1,904,084
Equity
Preferred stock, 1,000,000 shares authorized, $1,000 liquidation value Series B non-cumulative convertible; 445 shares and 445 shares outstanding at March 31, 2022 and December 31, 2021, respectively	445	445
Common stock, $0.10 par value; authorized 15,000,000 shares; Issued: 12,198,019 shares and 12,182,081 shares at March 31, 2022 and December 31, 2021, respectively	1,220	1,218
Additional paid-in capital	135,623	135,451
Retained earnings	106,194	98,017
Accumulated other comprehensive (loss) income	(188)	245
Treasury stock, 284,522 shares at March 31, 2022 and Dec. 31, 2021, at cost	(3,015)	(3,015)
Total shareholders’ equity	240,279	232,361
Total liabilities and equity	$ 2,054,191	$ 2,136,445